ALNYLAM PHARMACEUTICALS, INC. Total Contract Liability
ALNYLAM PHARMACEUTICALS, INC. (ALNY) had Total Contract Liability of $55.48 million as of 2024-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2025-02-13
- 2024-12-31: Contract with Customer, Liability $55.48M.
- 2023-12-31: Contract with Customer, Liability $290.76M.
- 2022-12-31: Contract with Customer, Liability $235.53M.
- 2022-09-30: Contract with Customer, Liability $73.63M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2024-12-31 | $55.48M 10-K · filed 2025-02-13 |
| 2023-12-31 | $290.76M 10-K · filed 2025-02-13 |
| 2022-12-31 | $235.53M 10-K · filed 2024-02-15 |
| 2022-09-30 | $73.63M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $80.65M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $78.68M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $88.63M 10-K · filed 2023-02-23 |
| 2021-09-30 | $76.45M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $82.26M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $94.76M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $120.02M 10-K · filed 2022-02-10 |
| 2020-09-30 | $145.69M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $152.26M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $152.83M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $153.12M 10-K · filed 2021-02-11 |
| 2019-09-30 | $158.45M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $403.03M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $3.03M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $3.95M 10-K · filed 2020-02-13 |
| 2018-09-30 | $5.07M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $13.68M 10-Q · filed 2018-08-02 |
| 2018-01-01 | $16.57M 10-K · filed 2019-02-14 |
| 2017-12-31 | $16.57M 10-K · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |